2luo: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
New page: '''Unreleased structure''' The entry 2luo is ON HOLD Authors: Stehle, T., Sreeramulu, S., Loehr, F., Richter, C., Saxena, K., Jonker, H.R.A., Schwalbe, H. Description: NMR solution str...
 
No edit summary
 
(10 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Unreleased structure'''


The entry 2luo is ON HOLD
==NMR solution structure of apo-MptpA==
<StructureSection load='2luo' size='340' side='right'caption='[[2luo]]' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[2luo]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Mycobacterium tuberculosis]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2LUO OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2LUO FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2luo FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2luo OCA], [https://pdbe.org/2luo PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2luo RCSB], [https://www.ebi.ac.uk/pdbsum/2luo PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2luo ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/PTPA_MYCTU PTPA_MYCTU] Mediates host-pathogen interaction and interferes with vesicular trafficking in the infected macrophage. Inhibits host phagolysosomal fusion in M.tuberculosis-infected macrophages to promote bacteria survival. Dephosphorylates host VPS33B protein, which induces a block of the host phagosome maturation within macrophage cells. Acts on tyrosine phosphorylated proteins, low-MW aryl phosphates and natural and synthetic acyl phosphates.
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Protein tyrosine phosphatases and kinases (PTPs and PTKs) co-regulate cellular processes. In pathogenic bacteria, they are frequently exploited to act as key virulence factors for human diseases. Mycobacterium tuberculosis (Mtb), the causative organism of tuberculosis (TB), secretes a low-molecular-weight (LMW)-PTP, MptpA, which is required for its survival upon infection of host macrophages. Although there is otherwise no sequence similarity of LMW-PTPs to other classes of PTPs, the phosphate binding loop (P-loop) CX5R and the loop containing a critical aspartic acid residue (D-loop), required for the catalytic activity, are well conserved. In most high-molecular-weight (HMW)-PTPs, ligand binding to the P-loop triggers a large conformational reorientation of the D-loop, in which it moves ~10 A, from an ''open'' to a ''closed'' conformation. Until now, there have been no ligand-free structures of LMW-PTPs described and hence the dynamics of the D-loop has remained largely unknown for these PTPs. Here, we present a high-resolution solution NMR structure of the free form of the MptpA LMW-PTP. In the absence of ligand and phosphate ions, the D-loop adopts an open conformation. Furthermore, we characterized the binding site of phosphate, a competitive inhibitor of LMW-PTPs, on MptpA and elucidated the involvement of both the P- and D-loop in phosphate binding. Notably, in LMW-PTPs, the phosphorylation status of two well conserved tyrosine residues, typically located in the D-loop, regulates the enzyme activity. PtkA, the kinase complementary to MptpA, phosphorylates these two tyrosine residues in MptpA. We characterized the MptpA-PtkA interaction by NMR spectroscopy to show that both P- and D-loop form part of the binding interface.


Authors: Stehle, T., Sreeramulu, S., Loehr, F., Richter, C., Saxena, K., Jonker, H.R.A., Schwalbe, H.
The apo-structure of the low-molecular-weight protein tyrosine phosphatase A (MptpA) from Mycobacterium tuberculosis allows for better target-specific drug development.,Stehle T, Sreeramulu S, Lohr F, Richter C, Saxena K, Jonker HR, Schwalbe H J Biol Chem. 2012 Aug 10. PMID:22888002<ref>PMID:22888002</ref>


Description: NMR solution structure of apo-MptpA
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 2luo" style="background-color:#fffaf0;"></div>
 
==See Also==
*[[Tyrosine phosphatase 3D structures|Tyrosine phosphatase 3D structures]]
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Large Structures]]
[[Category: Mycobacterium tuberculosis]]
[[Category: Jonker HRA]]
[[Category: Loehr F]]
[[Category: Richter C]]
[[Category: Saxena K]]
[[Category: Schwalbe H]]
[[Category: Sreeramulu S]]
[[Category: Stehle T]]

Latest revision as of 08:52, 15 May 2024

NMR solution structure of apo-MptpANMR solution structure of apo-MptpA

Structural highlights

2luo is a 1 chain structure with sequence from Mycobacterium tuberculosis. Full experimental information is available from OCA. For a guided tour on the structure components use FirstGlance.
Method:Solution NMR
Resources:FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Function

PTPA_MYCTU Mediates host-pathogen interaction and interferes with vesicular trafficking in the infected macrophage. Inhibits host phagolysosomal fusion in M.tuberculosis-infected macrophages to promote bacteria survival. Dephosphorylates host VPS33B protein, which induces a block of the host phagosome maturation within macrophage cells. Acts on tyrosine phosphorylated proteins, low-MW aryl phosphates and natural and synthetic acyl phosphates.

Publication Abstract from PubMed

Protein tyrosine phosphatases and kinases (PTPs and PTKs) co-regulate cellular processes. In pathogenic bacteria, they are frequently exploited to act as key virulence factors for human diseases. Mycobacterium tuberculosis (Mtb), the causative organism of tuberculosis (TB), secretes a low-molecular-weight (LMW)-PTP, MptpA, which is required for its survival upon infection of host macrophages. Although there is otherwise no sequence similarity of LMW-PTPs to other classes of PTPs, the phosphate binding loop (P-loop) CX5R and the loop containing a critical aspartic acid residue (D-loop), required for the catalytic activity, are well conserved. In most high-molecular-weight (HMW)-PTPs, ligand binding to the P-loop triggers a large conformational reorientation of the D-loop, in which it moves ~10 A, from an open to a closed conformation. Until now, there have been no ligand-free structures of LMW-PTPs described and hence the dynamics of the D-loop has remained largely unknown for these PTPs. Here, we present a high-resolution solution NMR structure of the free form of the MptpA LMW-PTP. In the absence of ligand and phosphate ions, the D-loop adopts an open conformation. Furthermore, we characterized the binding site of phosphate, a competitive inhibitor of LMW-PTPs, on MptpA and elucidated the involvement of both the P- and D-loop in phosphate binding. Notably, in LMW-PTPs, the phosphorylation status of two well conserved tyrosine residues, typically located in the D-loop, regulates the enzyme activity. PtkA, the kinase complementary to MptpA, phosphorylates these two tyrosine residues in MptpA. We characterized the MptpA-PtkA interaction by NMR spectroscopy to show that both P- and D-loop form part of the binding interface.

The apo-structure of the low-molecular-weight protein tyrosine phosphatase A (MptpA) from Mycobacterium tuberculosis allows for better target-specific drug development.,Stehle T, Sreeramulu S, Lohr F, Richter C, Saxena K, Jonker HR, Schwalbe H J Biol Chem. 2012 Aug 10. PMID:22888002[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

See Also

References

  1. Stehle T, Sreeramulu S, Lohr F, Richter C, Saxena K, Jonker HR, Schwalbe H. The apo-structure of the low-molecular-weight protein tyrosine phosphatase A (MptpA) from Mycobacterium tuberculosis allows for better target-specific drug development. J Biol Chem. 2012 Aug 10. PMID:22888002 doi:10.1074/jbc.M112.399261
Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA